Literature DB >> 15604787

High level production of bovine angiogenin in E. coli by an efficient refolding procedure.

Seung-Hwan Jang1, Dong-Ku Kang, Soo-Ik Chang, Harold A Scheraga, Hang-Cheol Shin.   

Abstract

Recombinant bovine angiogenin (rbAng) was expressed in E. coli at up to 30% of total cell proteins but was produced as inclusion bodies. By investigating the effect of various factors on the refolding yield, we obtained about 60% refolding. After chromatographic purification, about 60 mg purified angiogenin was obtained from 1 l culture. The purified recombinant bovine angiogenin was identical to native bovine angiogenin (nbAng) obtained from cow's milk. Our approach is highly efficient and can be generally used for the production of various types of angiogenin for functional and structural studies as well as therapeutic purposes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15604787     DOI: 10.1023/B:BILE.0000044452.57375.fb

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  3 in total

1.  Gold Nanoparticles Functionalized with Angiogenin for Wound Care Application.

Authors:  Lorena Maria Cucci; Giuseppe Trapani; Örjan Hansson; Diego La Mendola; Cristina Satriano
Journal:  Nanomaterials (Basel)       Date:  2021-01-14       Impact factor: 5.076

2.  A successful strategy for the recovering of active P21, an insoluble recombinant protein of Trypanosoma cruzi.

Authors:  Marlus Alves dos Santos; Francesco Brugnera Teixeira; Heline Hellen Teixeira Moreira; Adele Aud Rodrigues; Fabrício Castro Machado; Tatiana Mordente Clemente; Paula Cristina Brigido; Rebecca Tavares e Silva; Cecílio Purcino; Rafael Gonçalves Barbosa Gomes; Diana Bahia; Renato Arruda Mortara; Claudia Elisabeth Munte; Eduardo Horjales; Claudio Vieira da Silva
Journal:  Sci Rep       Date:  2014-03-04       Impact factor: 4.379

3.  A Tunable Nanoplatform of Nanogold Functionalised with Angiogenin Peptides for Anti-Angiogenic Therapy of Brain Tumours.

Authors:  Irina Naletova; Lorena Maria Cucci; Floriana D'Angeli; Carmelina Daniela Anfuso; Antonio Magrì; Diego La Mendola; Gabriella Lupo; Cristina Satriano
Journal:  Cancers (Basel)       Date:  2019-09-06       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.